For individuals of white European descent, certain variations of the gene HMGA1 are associated with Type 2 diabetes….

In men, FPG definitions yielded more incident cases of diabetes than HbA1c definitions, in contrast with women….

The investigational drug Bydureon used to treat Type 2 diabetes under development by Eli Lilly & Co., Amylin Pharmaceuticals Inc. and Alkermes Inc. failed to meet primary endpoints in a 26-week study…. 

Individuals with A1c ≥5.6% have an increased risk for future diabetes….

A research team, led by La Jolla Institute scientist Joel Linden, Ph.D., has shed new light on the problem of insulin resistance, and identified the key participants in a molecular pathway that holds therapeutic promise for reducing the severity of Type 2 diabetes…. 

Having an accumulation of fat in your liver cells may raise your risk of developing Type 2 diabetes regardless of the fat in other places of your body….

An analysis of previous studies indicates that among patients with a history of cardiovascular disease, but not hypertension, use of high blood pressure medication…. 

There was a lot of interest in the last two issues surrounding treatments for the complications of diabetes and, more specifically, neuropathy. This week we are focusing on the two most common forms of neuropathy: diabetic peripheral neuropathy (DPN) and diabetic autonomic neuropathy (DAN). To this end we have received …

The CDC just released new data in their 2011 fact sheet which got overlooked in most journals. They now estimate that 26.9% of all patients over 65 have diabetes. This is almost 11 million patients and many of them of them have had diabetes for less than 5 years. There …

by Janine Manning, PharmD Candidate LECOM School of Pharmacy   New technological advances over the past decade have led to extraordinary changes for those living with diabetes. Technology has allowed us to go from simply writing glucose values on paper to storing this information into glucometers or even using apps …